Christopher J. Clarke

8.0k total citations
125 papers, 6.4k citations indexed

About

Christopher J. Clarke is a scholar working on Molecular Biology, Cell Biology and Immunology. According to data from OpenAlex, Christopher J. Clarke has authored 125 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 29 papers in Cell Biology and 27 papers in Immunology. Recurrent topics in Christopher J. Clarke's work include Sphingolipid Metabolism and Signaling (42 papers), Lipid Membrane Structure and Behavior (19 papers) and Cellular transport and secretion (18 papers). Christopher J. Clarke is often cited by papers focused on Sphingolipid Metabolism and Signaling (42 papers), Lipid Membrane Structure and Behavior (19 papers) and Cellular transport and secretion (18 papers). Christopher J. Clarke collaborates with scholars based in United States, United Kingdom and Australia. Christopher J. Clarke's co-authors include Yusuf A. Hannun, Ricky W. Johnstone, Daniel J. Gough, David T. Levy, Bill X. Wu, Nicole L. Messina, Dianne Little, Hon Wai Lam, Lina M. Obeid and John N. Haselden and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Christopher J. Clarke

123 papers receiving 6.3k citations

Peers

Countries citing papers authored by Christopher J. Clarke

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Clarke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Clarke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Clarke more than expected).

Fields of papers citing papers by Christopher J. Clarke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Clarke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Clarke. The network helps show where Christopher J. Clarke may publish in the future.

Co-authorship network of co-authors of Christopher J. Clarke

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Clarke. A scholar is included among the top collaborators of Christopher J. Clarke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Clarke. Christopher J. Clarke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A comprehensive measure of Golgi sphingolipid flux using NBD C6-ceramide: evaluation of sphingolipid inhibitors 2024 ·Journal of Lipid Research ·(unknown), Justin M. Snider, Sitapriya Moorthi, Nicolas Coant, (unknown), Daniel Canals, Christopher J. Clarke, Chiara Luberto, Yusuf A. Hannun	3
2	Ca2+-activated sphingomyelin scrambling and turnover mediate ESCRT-independent lysosomal repair 2022 ·Nature Communications ·Patrick Niekamp, (unknown), (unknown), (unknown), Yeongho Kim, Yongqiang Deng, (unknown), (unknown), Mirco Imlau, Christopher J. Clarke, Michael Hensel, Christopher G. Burd, Joost C. M. Holthuis	66
3	Targeting sphingosine kinase 1 (SK1) enhances oncogene-induced senescence through ceramide synthase 2 (CerS2)-mediated generation of very-long-chain ceramides 2021 ·Cell Death and Disease ·(unknown), Christopher J. Clarke, Jeffrey L. Stith, Justin M. Snider, (unknown), Christopher Gault, Yusuf A. Hannun, Lina M. Obeid	12
4	Enantioselective Synthesis of Chiral Cyclopent‐2‐enones by Nickel‐Catalyzed Desymmetrization of Malonate Esters 2018 ·Angewandte Chemie ·Somnath Narayan Karad, (unknown), Christopher J. Clarke, William Lewis, Hon Wai Lam	13
5	Enantioselective Synthesis of Chiral Cyclopent‐2‐enones by Nickel‐Catalyzed Desymmetrization of Malonate Esters 2018 ·Angewandte Chemie International Edition ·Somnath Narayan Karad, (unknown), Christopher J. Clarke, William Lewis, Hon Wai Lam	69
6	Nickel-catalyzed, ligand-free, diastereoselective synthesis of 3-methyleneindan-1-ols 2018 ·Chemical Communications ·(unknown), Christopher J. Clarke, (unknown), Somnath Narayan Karad, William Lewis, Hon Wai Lam	8
7	Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injury 2017 ·Journal of Lipid Research ·Tess V. Dupre, Mark A. Doll, Parag P. Shah, Cierra N. Sharp, Deanna Siow, Judit Megyesi, James A. Shayman, Alicja Bielawska, Jacek Bielawski, Levi J. Beverly, María José Hernandez‐Corbacho, Christopher J. Clarke, Ashley J. Snider, Rick G. Schnellmann, Lina M. Obeid, Yusuf A. Hannun, Leah J. Siskind	41
8	Molecular and Biologic Analysis of Histone Deacetylase Inhibitors with Diverse Specificities 2013 ·Molecular Cancer Therapeutics ·Andrea Newbold, Geoffrey M. Matthews, Michael Bots, Leonie A. Cluse, Christopher J. Clarke, (unknown), Carleen Cullinane, Jessica E. Bolden, Ailsa J. Christiansen, Ross A. Dickins, Claudia Miccolo, Susanna Chiocca, Astrid M. Kral, Nicole Ozerova, Thomas A. Miller, Joey L. Methot, Victoria M. Richon, J. Paul Secrist, Saverio Minucci, Ricky W. Johnstone	40
9	Adiponectin Regulates Bone Mass via Opposite Central and Peripheral Mechanisms through FoxO1 2013 ·Cell Metabolism ·Daisuke Kajimura, Ha Won Lee, (unknown), Emilio Arteaga‐Solis, Mathieu Ferron, Bin Zhou, Christopher J. Clarke, Yusuf A. Hannun, Ronald A. DePinho, X. Edward Guo, (unknown), Gérard Karsenty	183
10	Off-Target Function of the Sonic Hedgehog Inhibitor Cyclopamine in Mediating Apoptosis via Nitric Oxide–Dependent Neutral Sphingomyelinase 2/Ceramide Induction 2012 ·Molecular Cancer Therapeutics ·Marisa Meyers‐Needham, (unknown), Salih Gencer, R. David Sentelle, Sahar A. Saddoughi, Christopher J. Clarke, Yusuf A. Hannun, Håkan Norell, Telma Martins da Palma, Michael I. Nishimura, Jacqueline M. Kraveka, Zohreh Khavandgar, Monzur Murshed, (unknown), Besim Öğretmen	33
11	Safety Study of Adeno-Associated Virus Serotype 2-Mediated Human Acid Sphingomyelinase Expression in the Nonhuman Primate Brain 2012 ·Human Gene Therapy ·Ernesto A. Salegio, Lluı́s Samaranch, Russell W. Jenkins, Christopher J. Clarke, (unknown), Janine Beyer, Adrian P. Kells, John R. Bringas, Waldy San Sebastián, R. Mark Richardson, (unknown), Yusuf A. Hannun, Krystof S. Bankiewicz, John Forsayeth	19
12	Assessment of the Accuracy and Reproducibility of RV Volume Measurements by CMR in Congenital Heart Disease 2012 ·JACC. Cardiovascular imaging ·Christopher J. Clarke, Matthew J. Gurka, Patrick T. Norton, Christopher M. Kramer, (unknown)	59
13	A cell-autonomous requirement for neutral sphingomyelinase 2 in bone mineralization 2011 ·The Journal of Cell Biology ·Zohreh Khavandgar, Christophe Poirier, Christopher J. Clarke, Jingjing Li, Nicholas Wang, Marc D. McKee, Yusuf A. Hannun, Monzur Murshed	63
14	Identification and Characterization of Murine Mitochondria-associated Neutral Sphingomyelinase (MA-nSMase), the Mammalian Sphingomyelin Phosphodiesterase 5 2010 ·Journal of Biological Chemistry ·Bill X. Wu, (unknown), Patrick Roddy, Christopher J. Clarke, Yusuf A. Hannun	110
15	Inducible activation of IFI 16 results in suppression of telomerase activity, growth suppression and induction of cellular senescence 2009 ·Journal of Cellular Biochemistry ·Christopher J. Clarke, Linda Hii, Jessica E. Bolden, Ricky W. Johnstone	17
16	Sphingomyelin metabolism at the plasma membrane: Implications for bioactive sphingolipids 2009 ·FEBS Letters ·Delphine Milhas, Christopher J. Clarke, Yusuf A. Hannun	165
17	The Role of p202 in Regulating Hematopoietic Cell Proliferation and Differentiation 2008 ·Journal of Interferon & Cytokine Research ·Louise Ludlow, Louise E. Purton, (unknown), Daniel J. Gough, Linda Hii, Joseph A. Trapani, Jonathan R. Keller, Christopher J. Clarke, Ricky W. Johnstone	12
18	A Novel c-Jun-dependent Signal Transduction Pathway Necessary for the Transcriptional Activation of Interferon γ Response Genes 2006 ·Journal of Biological Chemistry ·Daniel J. Gough, Kanaga Sabapathy, (unknown), (unknown), Robert D. Schreiber, Joseph A. Trapani, Christopher J. Clarke, Ricky W. Johnstone	56
19	Neutral sphingomyelinases and nSMase2: Bridging the gaps 2006 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Christopher J. Clarke, Yusuf A. Hannun	65
20	INTERLEUKIN 10 MODULATION OF TUMOUR NECROSIS FACTOR RECEPTORS REQUIRES TYROSINE KINASES BUT NOT THE PI 3-KINASE/p70 S6 KINASE PATHWAY 2000 ·Cytokine ·Lynn Williams, Ferdinand Lali, Christopher J. Clarke, Fionula M. Brennan, Brian M. J. Foxwell	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact